spacer
home > epc > spring 2009 > skin deep
PUBLICATIONS
European Pharmaceutical Contractor

Skin Deep

The safety battery for topically applied products typically includes evaluation of the final to-be-marketed formulation for cutaneous toxicity (most notably dermal irritation) potential for inducing contact sensitisation and photoallergic contact sensitisation, and phototoxic potential. Even though these Phase I safety studies are an integral part of almost every topical development programme and help lay the groundwork for responsible and safe clinical development in later phases, there are no current FDA or EMEA guidelines specific to these studies. Unfortunately, in the absence of guidelines setting down the requirements and designs for these studies, sponsors are often at a loss for rational designs and to manage agency expectations. This article presents an overview of the basic study designs for standard dermal safety tests in humans.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer

Betsy Hughes-Formella is Director of Business Development and Consulting at bioskin GmbH. She received her MS and PhD in Physiology from the University of Georgia, Athens, before moving to Germany to join a research team at the University Medical Center in Hamburg. Betsy’s research interests were in the areas of steroid biochemistry and the pathogenesis of melanoma. She joined bioskin in 1993. In her current role, she is responsible for the coordination of the company’s business development activities and is a consultant and advisor for clinical development concepts and study designs.

Joachim Fluhr has been Medical Director at bioskin GmbH since 2007. He received his MD at Johannes-Gutenberg-University of Mainz, Germany, and was trained in dermatology at the Department of Dermatology, Karlsruhe, Germany. He is a board-certified dermatologist. Joachim performed clinical trials in Karlsruhe and Pavia, Italy, before joining the UCSF-based team of Peter Elias in San Francisco for two years. After returning to Germany he was an attendant at the Friedrich-Schiller-University of Jena where he also headed the Skin physiology Laboratory for over four years. Currently, Joachim also holds a position as adjunct Lecturer in the Department of Dermatology, Charité, Berlin.

spacer
Betsy Hughes-Formella
spacer
spacer
spacer
Joachim Fluhr
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

MedPharm’s CSO and University of Reading Professor co-author new book on dermal formulation development

MedPharm’s Chief Scientific Officer and Co-Founder, Professor Marc Brown and University of Reading’s Professor Adrian Williams have co-authored the new book: ‘The Art and Science of Dermal Formulation Development”. It is the latest addition to ‘Drugs and the Pharmaceutical Sciences’, a series of textbooks and monographs published by CRC Press.
More info >>

White Papers

Exploring Protein Stability by nanoDSF

NanoTemper Technologies GmbH

nanoDSF determines thermal and chemical protein stability with ultra-high resolution and with unmatched reproducibility. The detection of the intrinsic tryptophan and tyrosin fluorescence enables measurements at close-to-native conditions in any buffer, even in the presence of detergents. nanoDSF is applied in antibody engineering, membrane protein research, formulation and quality control.
More info >>

 
Industry Events

SAPHEX 2019

23-24 October 2019, GALLAGHER CONVENTION CENTRE, 10 RICHARDS DRIVE, HALFWAY HOUSE, MIDRAND, 1685, SOUTH AFRICA

SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement